基本信息
views: 138
Career Trajectory
Bio
Area of Research: Molecular testing to guide cancer management, studies of targeted and other agents for the treatment of lung cancer, translational lung cancer biology such as oncogenic tyrosine kinase signaling and treatment resistance.
Dr. Halmos is an authority in the management of patients with malignancies of the thoracic cavity such as lung cancer, gastroesophageal cancer and thymoma. His research interests are focused on studies of targeted agents for the treatment of thoracic malignancies as well as translational studies aimed at different aspects of lung cancer biology such as oncogenic tyrosine kinase targeting, resistance to chemotherapy, radiation and targeted therapeutics. He will oversee the thoracic clinical trials program and spearhead the effort to develop guidelines for genetic testing for cancer patients of different anatomic sites to implement a personalized cancer medicine approach.
Dr. Halmos joined Montefiore and Einstein from Columbia University Medical Center, where he was Director of Thoracic Medical Oncology since 2009, Associate Professor of Medicine, and Chairman of the Cancer IRB. He completed a medical degree summa cum laude from Semmelweis University in Budapest, Hungary, an internal medicine residency at St.Luke’s-Roosevelt Hospital/Columbia University, and a hematology/oncology fellowship program at Beth Israel Deaconess Medical Center/Harvard Medical School, where he also obtained a master of science in clinical sciences from Harvard Medical School. Since completion of his fellowship, he has been on the faculties at Harvard, Case Western Reserve University, and Columbia.
Dr. Halmos is the recipient of multiple awards from organizations such as the American Society of Clinical Oncology, American Association for Cancer Research, and American Cancer Society and serves as a permanent review board member for the American Cancer Society. He is board certified in internal medicine and medical oncology.
Dr. Halmos is an authority in the management of patients with malignancies of the thoracic cavity such as lung cancer, gastroesophageal cancer and thymoma. His research interests are focused on studies of targeted agents for the treatment of thoracic malignancies as well as translational studies aimed at different aspects of lung cancer biology such as oncogenic tyrosine kinase targeting, resistance to chemotherapy, radiation and targeted therapeutics. He will oversee the thoracic clinical trials program and spearhead the effort to develop guidelines for genetic testing for cancer patients of different anatomic sites to implement a personalized cancer medicine approach.
Dr. Halmos joined Montefiore and Einstein from Columbia University Medical Center, where he was Director of Thoracic Medical Oncology since 2009, Associate Professor of Medicine, and Chairman of the Cancer IRB. He completed a medical degree summa cum laude from Semmelweis University in Budapest, Hungary, an internal medicine residency at St.Luke’s-Roosevelt Hospital/Columbia University, and a hematology/oncology fellowship program at Beth Israel Deaconess Medical Center/Harvard Medical School, where he also obtained a master of science in clinical sciences from Harvard Medical School. Since completion of his fellowship, he has been on the faculties at Harvard, Case Western Reserve University, and Columbia.
Dr. Halmos is the recipient of multiple awards from organizations such as the American Society of Clinical Oncology, American Association for Cancer Research, and American Cancer Society and serves as a permanent review board member for the American Cancer Society. He is board certified in internal medicine and medical oncology.
Research Interests
Papers共 392 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
LUNG CANCER (2024)
Luis Paz-Ares,Yasushi Goto,Darren Wan-Teck Lim,Balazs Halmos,Byoung Chul Cho,Manuel Cobo,José Luis González Larriba,Caicun Zhou,Ingel Demedts, Akin Atmaca,Sofia Baka,Bijoyesh Mookerjee,
Lung Cancer (2024): 107451-107451
CLINICAL LUNG CANCERno. 2 (2024): 159-167
Clinical Lung Cancerno. 3 (2024): 197-214
Federica Pecci,Seshiru Nakazawa,Biagio Ricciuti,Guilherme Harada, Jessica K. Lee,Joao V. Alessi,Adriana Barrichello,Victor R. Vaz,Giuseppe Lamberti,Alessandro Di Federico,Malini M. Gandhi, Dimitris Gazgalis,
Cancer Discovery (2024)
Pathology oncology research : POR (2024): 1611817-1611817
Karam Ashouri, Harris Krause,Andrew Elliott, Stephen V. Liu,Patrick C. Ma,Balazs Halmos,Zhaoxia Qu,Gutian Xiao,Ari Vanderwalde,Jorge J. Nieva
Cancer Researchno. 6_Supplement (2024): 5201-5201
Lauren K Young,Balazs Halmos
Cancer (2024)
Swartz Andrew,Andrew Elliott, George W. Sledge, Stephen V. Liu,Balazs Halmos,Vincent K. Lam,Taofeek K. Owonikoko
Cancer Researchno. 6_Supplement (2024): 3361-3361
Shirish M Gadgeel,Delvys Rodríguez-Abreu,Balazs Halmos, Marina C Garassino,Takayasu Kurata,Ying Cheng,Erin Jensen, Mark Shamoun, Kumar Rajagopalan,Luis Paz-Ares
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer (2024)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn